article thumbnail

Indivi to Collaborate with Biogen to Advance Digital Health Technology and Digital Biomarkers for Parkinson’s Disease

Digital Health Global

BASEL, Switzerland–(BUSINESS WIRE)–Indivi, a leading MedTech company headquartered in Basel, Switzerland, has entered into an agreement with Biogen to advance digital health technology and develop digital biomarkers for Parkinson’s disease.

article thumbnail

Colin Bower Joins VivoSense as Chief Executive Officer

Digital Health Global

Colin’s track record with global biopharma and biotech partners is extensive and admirable,” added Chris Garabedian, a VivoSense Board Member. “He He has consistently worked to improve the speed, safety, and cost-effectiveness of clinical trials through the adoption of new technological solutions. We are on Twitter.

BioTech 88
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

One on One Interview with Rachel Francine, CEO and Co-Founder of Music Health Technologies

Digital Health Today

My name is Rachel Francine and I am the co-founder and CEO of musical health technologies, we created a digital health platform, Singfit. Carrie: Tell me a little bit about yourself and what brings you to the Connected Health Conference? Digital Health Today would not be possible without our valuable partners.

article thumbnail

HealthTech Scotland Primed for Success: 80% of Scotland's Top Ten Start-ups are HealthTech related

Lloyd Price

The top three sectors for investment were: Digital health (£244 million) Therapeutics (£225 million) Medtech (£136 million) Some of the notable deals in 2022 included: Amphista Therapeutics (£38 million) Resolution Therapeutics (£34 million) ODx (£7.6 This talent pool is a major asset for the healthtech sector. (1)

article thumbnail

Scotland's Pioneering Spirit: A Legacy of Medical and Healthcare Innovation

Lloyd Price

The top three sectors for investment were: Digital health (£244 million) Therapeutics (£225 million) Medtech (£136 million) Some of the notable deals in 2022 included: Amphista Therapeutics (£38 million) Resolution Therapeutics (£34 million) ODx (£7.6 At the top is Glasgow-based Amphista Therapeutics, which raised $50m in 2022.

article thumbnail

Emerging trends in the European HealthTech M&A market 2023

Lloyd Price

The key trends that are expected to shape the market in 2023 include: Increased focus on digital health: Healthcare companies are increasingly looking to acquire digital health businesses in order to improve their offerings and stay ahead of the competition.